1. Daratumumab for relapsed AL amyloidosis—When cumulative real‐world data precedes clinical trials: A multisite study and systematic literature review. (9th November 2020) Authors: Shragai, Tamir; Gatt, Moshe; Lavie, Noa; Vaxman, Iuliana; Tadmor, Tamar; Rouvio, Ory; Zektser, Miri; Horowitz, Nethanel; Magen, Hila; Ballan, Mouna; Suru, Celia; Luttwak, Efrat; Levi, Shai; Ziv‐Baran, Tomer; Avivi, Irit; Cohen, Yael C. Journal: European journal of haematology Issue: Volume 106:Number 2(2021) Page Start: 184 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Daratumumab for relapsed AL amyloidosis—When cumulative real‐world data precedes clinical trials: A multisite study and systematic literature review. (9th November 2020) Authors: Shragai, Tamir; Gatt, Moshe; Lavie, Noa; Vaxman, Iuliana; Tadmor, Tamar; Rouvio, Ory; Zektser, Miri; Horowitz, Nethanel; Magen, Hila; Ballan, Mouna; Suru, Celia; Luttwak, Efrat; Levi, Shai; Ziv‐Baran, Tomer; Avivi, Irit; Cohen, Yael C. Journal: European journal of haematology Issue: Volume 106:Number 2(2021) Page Start: 184 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗